Yemetil 200mg Tablet contains Chlorpromazine, a typical antipsychotic agent belonging to the phenothiazine class, indicated primarily for the management of schizophrenia and other psychotic disorders. Chlorpromazine exerts its therapeutic effect by antagonizing dopamine D2 receptors in the brain, thereby reducing psychotic symptoms such as hallucinations, delusions, and agitation. Additionally, it has antiemetic, sedative, and anticholinergic properties, making it useful in treating severe nausea, vomiting, and intractable hiccups. Yemetil is also employed in managing acute manic phases of bipolar disorder and certain behavioral disorders. The tablet is administered orally, with dosage individualized based on the patient’s clinical condition, response, and tolerability. Common adverse effects include sedation, orthostatic hypotension, anticholinergic effects (dry mouth, constipation), extrapyramidal symptoms (tremors, rigidity), and potential metabolic disturbances. Caution is advised in patients with cardiovascular disease, epilepsy, liver impairment, and in the elderly due to increased sensitivity to side effects. Regular monitoring for tardive dyskinesia and other long-term adverse effects is recommended. Yemetil should be used under strict medical supervision, with gradual dose adjustments to minimize adverse reactions and optimize therapeutic outcomes.